Back
Protalix BioTherapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
PLX
Protalix BioTherapeutics
Last Price:
1.67
Seasonality Move:
78.33%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Protalix BioTherapeutics Stock Forecast
-
Is Protalix BioTherapeutics Stock Undervalued?
The current Protalix BioTherapeutics [PLX] share price is $1.69. The Score for PLX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal. - PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Protalix BioTherapeutics Stock Go Up Next Year?
Data Unavailable
Protalix BioTherapeutics Stock Rating
Data Unavailable
Protalix BioTherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protalix.com
52-Week Data
52-Week High:
1.90
52-Week Low:
0.82
Prediction Charts
Market Cap:
124.44M
Price in USD:
1.69
Volume:
817.07K
Beta:
0.66
Technical Analysis
SMA50:
1.15
SMA100:
1.10
SMA200:
1.19
52-Wk Change:
21.58%
Stock Predictions
-
Is Protalix BioTherapeutics stock public?
Yes, Protalix BioTherapeutics is a publicly traded company. -
What is the Protalix BioTherapeutics stock quote today?
The Protalix BioTherapeutics stock price is 1.69 USD today. -
How to buy Protalix BioTherapeutics stock online?
You can buy Protalix BioTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 1.19 | 1.25 | 1.26 | 1.18 |
| Nov-4 | 1.26 | 1.28 | 1.36 | 1.26 |
| Nov-5 | 1.30 | 1.30 | 1.32 | 1.27 |
| Nov-6 | 1.33 | 1.22 | 1.33 | 1.22 |
| Nov-7 | 1.19 | 1.16 | 1.24 | 1.16 |
| Nov-8 | 1.17 | 1.16 | 1.22 | 1.16 |
| Nov-11 | 1.18 | 1.20 | 1.21 | 1.18 |
| Nov-12 | 1.24 | 1.32 | 1.34 | 1.20 |
| Nov-13 | 1.29 | 1.24 | 1.31 | 1.23 |
| Nov-14 | 1.32 | 1.41 | 1.41 | 1.26 |
| Nov-15 | 1.37 | 1.40 | 1.41 | 1.33 |
| Nov-18 | 1.41 | 1.66 | 1.72 | 1.40 |
| Nov-19 | 1.66 | 1.63 | 1.75 | 1.58 |
| Nov-20 | 1.69 | 1.69 | 1.74 | 1.61 |
Protalix BioTherapeutics Earnings
Data Unavailable
Protalix BioTherapeutics Forecast Revenue Growth
Data Unavailable
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.